yocardial infarction (MI) is a multifactorial disease caused by environmental and genetic factors. There is an increasing number of studies that have identified the genes contributing to ischemic heart diseases (IHD) [1] [2] [3] [4] [5] [6] [7] [8] and recently, a mutation in the human MEF2A gene was reported as responsible for an autosomal dominant form of coronary artery disease (CAD). 9 The 7amino acid deletion disrupts the nuclear localization of the mature protein and reduces MEF2A-induced transcriptional activation. 9 The same authors have reported MEF2A missense mutations in 4 of 207 sporadic CAD cases and estimated that MEF2A mutations contribute to approximately 2% of CAD. 10 On the other hand, Weng et al recently reported a lack of MEF2A mutations in 300 CAD cases, 11 so the purpose of the present study was to assess the significance of MEF2A mutations in Japanese subjects with MI.
Methods

Study Population
The control group consisted of 589 subjects recruited from the Suita study who were at least 60 years of age with no cardiovascular disease and no family history IHD. The selection criteria and design of the Suita Study have been described previously. [12] [13] [14] We excluded young subjects from the control group, because they might develop MI in their 50 s and 60 s. The MI group consisted of 379 randomly selected inpatients and outpatients with documented MI who were admitted to the Division of Cardiology at the National Cardiovascular Center between May 2001 and April 2003 (MI group). 15 The characteristics of the study population are shown in Table 1 . All subjects gave written informed consent and the present study was approved by the Ethics Committee of the National Cardiovascular Center and by the Committee on Genetic Analysis and Gene Therapy of the National Cardiovascular Center.
DNA Studies
A promoter region and all of the 12 exon regions were sequenced in 190 of the subjects with MI ( Fig 1) and we found variations that altered the amino acid sequences in exon 12 only. Next, we sequenced exon 12 in 589 control subjects and the remaining 189 subjects with MI. The variations in exon 12 were all determined by sequencing.
Background Recently, a mutation in the human MEF2A gene was reported to be responsible for an autosomal dominant form of coronary artery disease, so the purpose of the present study was to assess the significance of MEF2A mutations in Japanese subjects with myocardial infarction (MI).
Methods and Results
The study population consisted of 589 control subjects recruited from the Suita study and 379 subjects with MI. The promoter, all the exons, and 3'-UTR regions of MEF2A were sequenced in 190 subjects with myocardial infarction. We found 2 amino acid length polymorphisms, a 7-amino acid deletion polymorphism, and a nonsense mutation (R447X) in exon 12. The length and deletion polymorphisms did not confer susceptibility to MI. Although the nonsense mutation was detected in 1 subject with MI, and in none of the control subjects, the impact of this mutation does not appear to be great; the subject had the MI while in his 70 s, had 2 major risk factors, and no family history of ischemic heart disease. Conclusion MEF2A polymorphism does not contribute appreciably to MI in the Japanese population. 
Results
We found 27 variations in MEF2A (Table 2) , and 4 variations in exon 12 that altered the amino acid sequence of the MEF2A protein (Fig 2) . The number of polyglutamine tandem repeats (region A) varied between 4 and 15 (genotype 1), and the number of proline tandem repeats (region B) varied between 4 and 5 (genotype 2). The 21-bp deletion (7-amino acid deletion), which was originally implicated in an autosomal dominant form of CAD, 9 was also observed in region C (genotype 3) ( Fig 2) . We found one nonsense mutation (R447X) in exon 12 in a MI subject, and it was localized just downstream of the 21-bp deletion site (Fig 3) .
The haplotype frequencies defined by the 3 genotypes are shown in Table 3 : there were no significant differences between the control and MI groups.
Discussion
Wang et al reported that a mutation in the human MEF2A gene was responsible for an autosomal dominant form of CAD, 9 but Weng et al could not find any MEF2A mutations in 300 cases of CAD. 11 Thus, the association between mutations of MEF2A and CAD is controversial, 16, 17 and our results favors a lack of association.
Our results indicate that length polymorphisms in MEF2A do not contribute appreciably to MI in the Japanese population. Furthermore, the 21-bp deletion in MEF2A, which was originally implicated, 9 did not seem to be associated with MI. The nonsense mutation (R447X) may affect susceptibility to MI, but the particular patient with this mutation had the MI in his 70 s, and had no family history of IHD. He also had 2 risk factors: diabetes mellitus and smoking. Thus, the impact of this mutation does not appear to be great.
We sequenced all the coding regions of MEF2A in 190 subjects with MI and found neither missense nor nonsense mutations, except for R447X. Taking all our results together, MEF2A polymorphism does not appear to contribute appreciably to MI in the Japanese population. In the polymorphisms found in the exons, mutations of the amino acid sequence are also indicated. The frequencies of haplotypes defined by genotypes 1-3 in the control (C) or myocardial infarction (MI) groups are shown. The haplotypes are defined as follows: A represents the number of polyglutamine tandem repeats between 4 and 15 (region A in Fig 2) ; B represents the number of proline tandem repeats between 4 and 5 (region B); and C+ or -represents the existence or deletion of the 21-bp nucleotide (region C).
